Saturday 7 November 2026 Export SNDX’s income statement to Excel — free account

Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $172.4 million, up 627.8% from fiscal 2024.

Revenue: +81.6%
EPS: +21.4%
Free cash flow: +61.4%
Total debt: +71.1%

Quarter to September 2026, against a year earlier

9.54 0.17 +1.81%

Follow SNDX

Alert me

Market cap: $843.6M
P/E: 0.0×
Fwd P/E: −6.7×
Dividend yield: —
F-score: n/a
Altman Z: −2.09
Beneish M: 3.29
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	—	—	4	4
ROE Full definition →		(161.82%)	(189.53%)	(255.93%)	(426.43%)
ROA Full definition →		(45.50%)	(43.70%)	(33.97%)	(33.67%)
ROIC Full definition →		0.00%	(573.79%)	(247.93%)	(83.42%)
Return on Tangible Assets Full definition →		(69.93%)	(63.15%)	(38.36%)	(46.90%)
Average Days of Receivables Full definition →		144.31	98.98	101.57	96.75
Free Cash Flow per Share Full definition →		(3.73)	(3.15)	(2.48)	(1.98)
Free Cash Flow Full definition →		(322.94)	(278.16)	(220.87)	(177.59)
Capital Expenditures Full definition →		0.04	—	(0.23)	(0.23)
Other line items
Cash ROIC Full definition →		(39.28%)	(37.25%)	(19.08%)	(17.61%)
Accounts Receivable Turnover Full definition →		4.34	5.55	4.78	4.91
Accounts Payable Turnover Full definition →		0.49	0.83	0.96	2.59
Inventory Turnover Full definition →		0.42	0.44	0.42	0.70
Average Days of Payables Full definition →		868.25	453.97	167.09	57.85
Days of Inventory on Hand Full definition →		1,715.24	1,463.18	1,136.93	637.55
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		150.15%	117.87%	103.89%	94.32%
Selling, General and Administrative Expense of Revenue Full definition →		104.25%	81.15%	69.04%	59.69%
Share Based Compensation of Revenue Full definition →		27.56%	22.64%	19.60%	18.18%
Interest Coverage Full definition →		(7.79)	(5.75)	(4.45)	(3.69)
Operating CF/Net income Full definition →		1.13	1.14	1.00	0.85
Depreciation/Fixed assets Full definition →		(58.12)	(44.77)	(23.94)	(20.09)
Capex/Depreciation Full definition →		0.00	0.00	0.04	0.05
Revenue per Share Full definition →		1.99	2.46	2.83	3.22
Operating CF per Share Full definition →		(3.73)	(3.15)	(2.48)	(1.98)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly